In the context of Capital Link's Deep Dive Series, Mr. Jerry Kalogiratos, CEO of Capital Clean Energy Carriers Corp. (NASDAQ: ...
Discussion - CCEC, CEO & Deputy Head of Research, Fearnley SecuritiesNEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- In the context of Capital Link’s Deep Dive Series, Mr. Jerry Kalogiratos, CEO of ...
In the context of Capital Link’s Deep Dive Series, Mr. Jerry Kalogiratos, CEO of Capital Clean Energy Carriers Corp. (NASDAQ: CCEC), joined Mr. Nils Thomessen, Deputy Head of Fearnley Securities, for ...
OC134 is an eye drop medicine candidate indicated for the topical treatment of moderate to severe allergic conjunctivitis, a condition for which a suitable non-steroidal topical ocular treatment, does ...